The PHOENIX group continued to grow in the first quarter. In the initial three months of fiscal year 2019/20 (February to April 2019), total operating performance rose by 4.1 per cent to €8.3 billion. This figure comprises revenue and handling for service charge. Adjusted for foreign exchange rate effects, this increase amounted to 4.5 per cent. With activities in 27 European countries, the healthcare provider’s revenue grew by €365.1 million (5.9 per cent) to €6.6 billion. Adjusted for foreign exchange rate effects, revenue grew by 6.0 per cent. The increase derived in particular from the Western Europe region as well as from Eastern Europe, where revenue growth was increased by the acquisition in Romania of the pharmaceutical wholesaler Farmexim and the nationwide pharmacy chain Help Net on 31 July 2018.
Income leap achieved
Earnings before interest, taxes, depreciation, and amortisation (EBITDA) rose by 16.6 per cent, or €15.4 million, versus the comparison period to €108.4 million. Profit for the period increased by 39.8 per cent. It grew by €13 million to €45.7 million.